Literature DB >> 24177179

HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization.

Azusa Tanaka-Nakanishi1, Jun-ichirou Yasunaga, Ken Takai, Masao Matsuoka.   

Abstract

As the infectious agent causing human adult T-cell leukemia (ATL), the human T-cell leukemia virus type 1 (HTLV-1) virus spreads in vivo primarily by cell-to-cell transmission. However, the factors that determine its transmission efficiency are not fully understood. The viral genome encodes the HTLV-1 bZIP factor (HBZ), which is expressed in all ATL cases and is known to promote T-cell proliferation. In this study, we investigated the hypothesis that HBZ also influences the survival of T cells. Through analyzing the transcriptional profile of HBZ-expressing cells, we learned that HBZ suppressed transcription of the proapoptotic gene Bim (Bcl2l11) and that HBZ-expressing cells were resistant to activation-induced apoptosis. Mechanistic investigations into how HBZ suppresses Bim expression revealed that HBZ perturbs the localization and function of FoxO3a, a critical transcriptional activator of the genes encoding Bim and also Fas ligand (FasL). By interacting with FoxO3a, HBZ not only attenuated DNA binding by FoxO3a but also sequestered the inactive form of FoxO3a in the nucleus. In a similar manner, HBZ also inhibited FasL transcription induced by T-cell activation. Further study of ATL cells identified other Bim perturbations by HBZ, including at the level of epigenetic alteration, histone modification in the promoter region of the Bim gene. Collectively, our results indicated that HBZ impairs transcription of the Bim and FasL genes by disrupting FoxO3a function, broadening understanding of how HBZ acts to promote proliferation of HTLV-1-infected T cells by blocking their apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24177179     DOI: 10.1158/0008-5472.CAN-13-0436

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

Review 1.  Human T-cell lymphotropic virus type 1 and its oncogenesis.

Authors:  Lan-Lan Zhang; Jing-Yun Wei; Long Wang; Shi-le Huang; Ji-Long Chen
Journal:  Acta Pharmacol Sin       Date:  2017-04-10       Impact factor: 6.150

2.  The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.

Authors:  Amanda W Rushing; Kimson Hoang; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

3.  Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles.

Authors:  Jane Murphy; William W Hall; Lee Ratner; Noreen Sheehy
Journal:  Virology       Date:  2016-04-22       Impact factor: 3.616

Review 4.  Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and Persistence.

Authors:  Alexandre Carpentier; Pierre-Yves Barez; Malik Hamaidia; Hélène Gazon; Alix de Brogniez; Srikanth Perike; Nicolas Gillet; Luc Willems
Journal:  Viruses       Date:  2015-07-07       Impact factor: 5.048

5.  Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.

Authors:  Takayuki Takachi; Masahiko Takahashi; Manami Takahashi-Yoshita; Masaya Higuchi; Miki Obata; Yukio Mishima; Shujiro Okuda; Yuetsu Tanaka; Masao Matsuoka; Akihiko Saitoh; Patrick L Green; Masahiro Fujii
Journal:  Cancer Sci       Date:  2015-03-16       Impact factor: 6.716

Review 6.  From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis.

Authors:  Eléonore Pérès; Eugénie Bagdassarian; Sébastien This; Julien Villaudy; Dominique Rigal; Louis Gazzolo; Madeleine Duc Dodon
Journal:  Viruses       Date:  2015-12-07       Impact factor: 5.048

7.  HTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cells.

Authors:  David Olagnier; Alexandre Sze; Samar Bel Hadj; Cindy Chiang; Courtney Steel; Xiaoying Han; Jean-Pierre Routy; Rongtuan Lin; John Hiscott; Julien van Grevenynghe
Journal:  PLoS Pathog       Date:  2014-12-18       Impact factor: 6.823

8.  Identification and characterization of HTLV-1 HBZ post-translational modifications.

Authors:  Nathan Dissinger; Nikoloz Shkriabai; Sonja Hess; Jacob Al-Saleem; Mamuka Kvaratskhelia; Patrick L Green
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

9.  Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.

Authors:  Diana G Wright; Claire Marchal; Kimson Hoang; John A Ankney; Stephanie T Nguyen; Amanda W Rushing; Nicholas Polakowski; Benoit Miotto; Isabelle Lemasson
Journal:  Oncotarget       Date:  2016-01-12

10.  Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression.

Authors:  Aileen G Rowan; Koichiro Suemori; Hiroshi Fujiwara; Masaki Yasukawa; Yuetsu Tanaka; Graham P Taylor; Charles R M Bangham
Journal:  Retrovirology       Date:  2014-12-14       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.